Thyssenkrupp Nucera Shares Under Pressure Following Guidance Cut

Thyssenkrupp Nucera slashes its annual revenue and profit forecast, sending shares to a new low, even as it secures a key 300MW electrolyzer contract in Spain.

Investors in Thyssenkrupp Nucera are facing a complex narrative. While the hydrogen specialist, a subsidiary of Thyssenkrupp, has secured a significant 300-megawatt contract in Spain, it has simultaneously been forced to issue a substantial downgrade to its annual financial outlook. This conflicting news flow has sent the stock to a new annual low, highlighting the near-term challenges of scaling green hydrogen production.

Revised Outlook Weighs on Sentiment

The primary driver behind the recent sell-off is a stark revision of the company's forecasts for the current fiscal year. Management now anticipates revenue to fall within a range of 450 to 550 million euros, a downward adjustment from previous expectations. More critically, the projected operating loss (EBIT) has widened, with estimates now reaching up to 80 million euros in negative territory. This deterioration is attributed to steep upfront costs associated with ramping up green hydrogen production capacity, compounded by a halted project in the United States. The market's reaction was swift: shares closed the week down nearly four percent, hitting a new 52-week low at precisely 7.72 euros.

Major Spanish Contract Provides a Strategic Silver Lining

Offsetting the financial strain is a notable operational achievement. The company has finalized an agreement with the Spanish firm Moeve to supply 15 electrolyzers for the "Onuba" project. Located in Huelva, the facility is poised to become Southern Europe's largest green hydrogen plant. This deal reinforces Nucera's technological standing within a burgeoning market, albeit one that remains heavily reliant on government subsidies for growth.

Market strategists are adopting a cautious stance in light of the mixed signals. Analysts at Goldman Sachs, for instance, have slightly reduced their price target to 9.00 euros while maintaining a "Neutral" rating. Their assessment suggests the business may not reach its cyclical low point until the 2025/26 timeframe.

Navigating a Volatile Sector with Project Backlog

The broader hydrogen sector continues to demonstrate volatility, as evidenced by recent cancellations of major competing projects in the Netherlands. For Nucera, contracts like the one in Spain enhance order book visibility, but the necessary pre-investments continue to severely pressure near-term profitability. Analysts note that investors must endure a period of transition until scaling effects within the electrolysis division begin to outpace costs. The company's existing project pipeline is now viewed as a critical buffer to operationally bridge what is forecasted to be a challenging period leading up to 2026.